0
Editor's Correspondence |

Selenium and HIV-1: Hope or Hype?

Catherine Passaretti, MD; Amita Gupta, MD, MHS
Arch Intern Med. 2007;167(22):2530-2531. doi:10.1001/archinte.167.22.2530-b.
Text Size: A A A
Published online

Extract

We read with great interest the article by Hurwitz et al1 on the impact of selenium supplementation in patients infected with human immunodeficiency virus type 1 (HIV-1). Studies examining the association between micronutrients and HIV, particularly prospective studies, have been limited to date.2 Hurwitz et al1 evaluated the association between selenium supplementation and HIV-1 viral load in a randomized, double-blind, placebo-controlled trial in 262 HIV-infected adults. Human immunodeficiency virus type 1 viral load and CD4 cell count were checked at baseline and at 9 months. Selenium plasma levels and medication adherence were monitored monthly. Based on their results, the authors concluded that daily selenium supplementation can be used as “a simple, inexpensive, and safe adjunct therapy in HIV spectrum disease.”1(p153) Using the CONSORT (Consolidated Standards of Reporting Trials) guidelines for publication of randomized controlled trials3 as well as our assessment of data presented, we found several shortcomings of this study that call into question whether this conclusion is justified.

Topics

selenium ; hiv-1

Sign In to Access Full Content

Don't have Access?

Register and get free email Table of Contents alerts, saved searches, PowerPoint downloads, CME quizzes, and more

Subscribe for full-text access to content from 1998 forward and a host of useful features

Activate your current subscription (AMA members and current subscribers)

Purchase Online Access to this article for 24 hours

First Page Preview

View Large
/>
First page PDF preview

Figures

Tables

References

Correspondence

CME
Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.
NOTE:
Citing articles are presented as examples only. In non-demo SCM6 implementation, integration with CrossRef’s "Cited By" API will populate this tab (http://www.crossref.org/citedby.html).
Submit a Comment

Multimedia

Some tools below are only available to our subscribers or users with an online account.

Sign In to Access Full Content

Related Content

Customize your page view by dragging & repositioning the boxes below.

Articles Related By Topic
Related Topics
PubMed Articles
Jobs
brightcove.createExperiences();